PLX
Bashan Dror, PLX's CEO, spent $101.4K of their own money on 56,000 shares at $2, growing their stake 42%.
+$101.4K
56,000 sh @ $2
PLX
Protalix BioTherapeutics, Inc.
SEC CIK 1006281
$2.07
−29.0% · 90 days
90-day buys
$0
0 open-market
90-day sells
$0
0 open-market
Net insider flow
+$0
Net buying
Filings shown
19
Most recent
Advertisement
At a glance
Insiders at PLX have made no open-market trades in the last 90 days — the activity below is grants, option exercises, and other routine filings.
Largest recent trade: Schwartz Aharon, PLX's Director, spent $205.9K of their own money on 129,000 shares at $2, growing their stake 74%.
Most active filer: Bashan Dror, with 6 transactions among the recent filings shown.
Insider transaction history
Form 4 filings for PLX, newest firstPLX
−$314
168 sh @ $2
PLX
+$0
7,500 sh
PLX
+$0
7,500 sh
PLX
+$0
7,500 sh
Advertisement
PLX
+$0
7,500 sh
PLX
+$0
7,500 sh
PLX
+$0
7,500 sh
PLX
+$0
7,500 sh
PLX
+$0
25,000 sh
PLX
+$0
195,000 sh
PLX
Schwartz Aharon, PLX's Director, spent $205.9K of their own money on 129,000 shares at $2, growing their stake 74%.
+$205.9K
129,000 sh @ $2
PLX
+$0
99,010 sh
PLX
+$0
263,960 sh
PLX
Bashan Dror, PLX's CEO, spent $67.7K of their own money on 48,387 shares at $1, growing their stake 71%.
+$67.7K
48,387 sh @ $1
PLX
Bashan Dror, PLX's CEO, spent $22.7K of their own money on 16,129 shares at $1, growing their stake 14%.
+$22.7K
16,129 sh @ $1
PLX
+$0
800,000 sh
PLX
+$0
201,903 sh
PLX
+$0
35,115 sh
Advertisement
About PLX insider activity
This page tracks every recent Form 4 filed for Protalix BioTherapeutics, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.
The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.
Frequently asked questions
How often is PLX insider data updated?
Continuously. We read from SEC EDGAR, so new Form 4 filings for Protalix BioTherapeutics, Inc. usually appear here within minutes of being accepted by the SEC.
What does "net insider flow" mean?
It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.
Why do some rows show grants or option exercises instead of buys?
Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.
Is this investment advice?
No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.